Par Drugs & Chemicals Ltd share price logo

Par Drugs & Chemicals Ltd Share Price (PAR)

Check the latest share price of Par Drugs & Chemicals Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹97.850.15%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Par Drugs & Chemicals Ltd Stock Performance

Get live Par Drugs & Chemicals Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹96.7
    Day's Price Range
    ₹98.7
  • 52 Week's Low

    52 Week's High

    ₹81.01
    52-Week Price Range
    ₹348.45
1 Month Return-2.39 %
3 Month Return+ 3.21 %
1 Year Return-56.4 %
3 Year Return-34.98 %
5 Year Return+ 420.48 %
Previous Close₹98.00
Open₹97.50
Volume4,339.00
Upper Circuit₹102.90
Lower Circuit₹93.10

Par Drugs & Chemicals Ltd Fundamentals & Key Indicators

Check Par Drugs & Chemicals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹120.40 Cr

Return on Equity (ROE)

18.49

PE Ratio (TTM)

0

Return on capital employed (ROCE)

25.01

Beta (LTM)

1.02

P/B Ratio

3.1

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-55.65

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

How to invest in Par Drugs & Chemicals Ltd?

Investing in Par Drugs & Chemicals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Par Drugs & Chemicals Ltd or PAR on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Par Drugs & Chemicals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Par Drugs & Chemicals Ltd with just a few clicks!

Par Drugs & Chemicals Ltd Stock's Interest Amongst Investors

-4%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Search interest for Par Drugs & Chemicals Ltd Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Par Drugs & Chemicals Ltd Financial Results

Get the annual and quarterly financial summary of Par Drugs & Chemicals Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

23 (0%)23 (1%)35 (53%)21 (38%)22 (4%)
Net Income

(in ₹ Cr)

4 (0%)3 (32%)9 (240%)1 (93%)2 (184%)
Net Profit Margin16.30% (0%)11.19% (31%)24.81% (122%)2.71% (89%)7.39% (173%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

77 (0%)79 (3%)89 (13%)102 (14%)
Total Liabilities

(in ₹ Cr)

24 (0%)19 (22%)18 (6%)16 (10%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

8 (0%)12 (57%)8 (37%)13 (76%)20 (51%)

Par Drugs & Chemicals Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Par Drugs & Chemicals Ltd.

  • Par Drugs & Chemicals Ltd Earnings Results

    Par Drugs & Chemicals Ltd’s net profit fell -55.65% since last year same period to ₹1.65Cr in the Q4 2024-2025. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 184.48% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Par Drugs & Chemicals Ltd Dividends November,2021

    In the quarter ending September 2021, Par Drugs & Chemicals Ltd has declared dividend of ₹1.25 - translating a dividend yield of 1.28%.

    Read More about Dividends

Par Drugs & Chemicals Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Par Drugs & Chemicals Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
73.37%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
26.63%
0.00
Others
0%
0.00

Par Drugs & Chemicals Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Par Drugs & Chemicals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA120.4084.1%0.501495
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245

Par Drugs & Chemicals Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Par Drugs & Chemicals Ltd.

  • Par Drugs Reports Significant Profit Decline - 09 May, 2025

    Par Drugs & Chemicals reported a 55.65% decline in standalone net profit to Rs 1.65 crore for Q1 FY2025, compared to Rs 3.72 crore in Q1 FY2024. Sales also fell by 2.15% to Rs 22.33 crore. For the full year, net profit decreased by 7.86% to Rs 13.36 crore, despite a 5.57% increase in annual sales to Rs 100.97 crore.

Insights on Par Drugs & Chemicals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 166.1%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 26.63% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 101.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 73.37% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, PAR stock has moved down by -56.0%

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited is an Indian company which is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for both domestic and international markets. It was initially incorporated as a private limited company in Bhavnagar, Gujarat and later converted into a public limited company in October 2018. It has two manufacturing facilities at Bhavnagar and Ankleshwar in Gujarat, comprising of 3 manufacturing blocks for APIs and 2 for Fine Chemicals in Bhavnagar. The company produces a range of popular antacid molecules and markets a total of 12 APIs and 6 Fine Chemicals domestically and for exports to 16 countries. Key customers of the company include Essential Drugs Company Limited, Taurus Chemicals P Limited, Pfizer Limited, United Phosphorus Limited, Samba Jammu Unit and Shiv Silica Private Limited.

Revenue: ₹22.33Cr as on March 2025 (Q4 FY25)
Net Profit: ₹1.65Cr as on March 2025 (Q4 FY25)
Listing date: 16 May, 2019
Chairperson Name: FALGUN VALLABHBHAI SAVANI
OrganisationPar Drugs & Chemicals Ltd
IndustryPharmaceuticals
CEOFALGUN VALLABHBHAI SAVANI
E-voting on sharesClick here to vote

FAQs

What is Par Drugs & Chemicals Ltd share price today?

Par Drugs & Chemicals Ltd share price today stands at ₹97.85, Open: ₹97.5, Previous Close: ₹98, High: ₹98.7, Low: ₹96.7, 52 Week High: ₹348.45, 52 Week Low: ₹81.01.

What is today's traded volume of Par Drugs & Chemicals Ltd?

Today's traded volume of Par Drugs & Chemicals Ltd is 4,339.00. Which means that 4,339.00 shares of Par Drugs & Chemicals Ltd were bought and sold on the stock market during today's trading session.

What is Par Drugs & Chemicals Ltd's market cap today?

Today's market capitalisation of Par Drugs & Chemicals Ltd is ₹120.40 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Par Drugs & Chemicals Ltd?

Par Drugs & Chemicals Ltd’s 52 week high is ₹348.45 and 52 week low is ₹81.01. The current share price of Par Drugs & Chemicals Ltd is ₹97.85, which is -71.92% down from its 52 week high and 20.79% up from its 52 week low.